151 related articles for article (PubMed ID: 24954628)
1. The effect of care setting in the delivery of high-value colon cancer care.
Veenstra CM; Epstein AJ; Liao K; Morris AM; Pollack CE; Armstrong KA
Cancer; 2014 Oct; 120(20):3237-44. PubMed ID: 24954628
[TBL] [Abstract][Full Text] [Related]
2. Hospital academic status and value of care for nonmetastatic colon cancer.
Veenstra CM; Epstein AJ; Liao K; Griggs JJ; Pollack CE; Armstrong K
J Oncol Pract; 2015 May; 11(3):e304-12. PubMed ID: 25901052
[TBL] [Abstract][Full Text] [Related]
3. The Value of Continuity between Primary Care and Surgical Care in Colon Cancer.
Hussain T; Chang HY; Luu NP; Pollack CE
PLoS One; 2016; 11(5):e0155789. PubMed ID: 27219454
[TBL] [Abstract][Full Text] [Related]
4. Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.
Hussain T; Chang HY; Veenstra CM; Pollack CE
J Oncol Pract; 2015 May; 11(3):e388-97. PubMed ID: 25873063
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
[TBL] [Abstract][Full Text] [Related]
6. Fragmentation in specialist care and stage III colon cancer.
Hussain T; Chang HY; Veenstra CM; Pollack CE
Cancer; 2015 Sep; 121(18):3316-24. PubMed ID: 26043368
[TBL] [Abstract][Full Text] [Related]
7. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
[TBL] [Abstract][Full Text] [Related]
9. The association between post-treatment surveillance testing and survival in stage II and III colon cancer patients: An observational comparative effectiveness study.
Hines RB; Jiban MJH; Specogna AV; Vishnubhotla P; Lee E; Zhang S
BMC Cancer; 2019 May; 19(1):418. PubMed ID: 31053096
[TBL] [Abstract][Full Text] [Related]
10. Hospital Variation in Spending for Lung Cancer Resection in Medicare Beneficiaries.
Jean RA; Bongiovanni T; Soulos PR; Chiu AS; Herrin J; Kim N; Xu X; Kim AW; Gross CP
Ann Thorac Surg; 2019 Dec; 108(6):1710-1716. PubMed ID: 31400321
[TBL] [Abstract][Full Text] [Related]
11. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer.
Kwan SW; Mortell KE; Hippe DS; Brunner MC
J Vasc Interv Radiol; 2014 Oct; 25(10):1558-64; quiz 1565. PubMed ID: 25130308
[TBL] [Abstract][Full Text] [Related]
12. Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.
Mullins CD; Hsiao FY; Onukwugha E; Pandya NB; Hanna N
Cancer; 2012 Jun; 118(12):3173-81. PubMed ID: 22020739
[TBL] [Abstract][Full Text] [Related]
13. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.
Gross CP; Andersen MS; Krumholz HM; McAvay GJ; Proctor D; Tinetti ME
JAMA; 2006 Dec; 296(23):2815-22. PubMed ID: 17179458
[TBL] [Abstract][Full Text] [Related]
14. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
15. Do certified cancer centers provide more cost-effective care? A health economic analysis of colon cancer care in Germany using administrative data.
Cheng CY; Datzmann T; Hernandez D; Schmitt J; Schlander M
Int J Cancer; 2021 Nov; 149(10):1744-1754. PubMed ID: 34213799
[TBL] [Abstract][Full Text] [Related]
16. Yttrium-90 Radioembolization Is Cost Effective in Intrahepatic Cholangiocarcinoma: A SEER Medicare Population Study.
Ghodadra A; Xing M; Zhang D; Kim HS
J Vasc Interv Radiol; 2019 Mar; 30(3):293-297. PubMed ID: 30819468
[TBL] [Abstract][Full Text] [Related]
17. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
[TBL] [Abstract][Full Text] [Related]
18. Hospital lymph node examination rates and survival after resection for colon cancer.
Wong SL; Ji H; Hollenbeck BK; Morris AM; Baser O; Birkmeyer JD
JAMA; 2007 Nov; 298(18):2149-54. PubMed ID: 18000198
[TBL] [Abstract][Full Text] [Related]
19. Provider treatment intensity and outcomes for patients with early-stage bladder cancer.
Hollenbeck BK; Ye Z; Dunn RL; Montie JE; Birkmeyer JD
J Natl Cancer Inst; 2009 Apr; 101(8):571-80. PubMed ID: 19351919
[TBL] [Abstract][Full Text] [Related]
20. Readmissions After Colon Cancer Surgery: Does It Matter Where Patients Are Readmitted?
Luu NP; Hussain T; Chang HY; Pfoh E; Pollack CE
J Oncol Pract; 2016 May; 12(5):e502-12. PubMed ID: 27048614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
